Association Between Thiazolidinedione Treatment and Risk of Macular Edema Among Patients With Type 2 Diabetes

Jul-12

AUTHORS : Dr Iskandar Idris, University of Nottingham, Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, Royal Derby Hospital , Uttoxeter Road, Derby DE22 3DT – Email: Iskandar.Idris@nottingham.ac.uk – Profile: https://www.nottingham.ac.uk/medicine/people/iskandar.idris (Details for this study: Department of Diabetes and Endocrinology, Kings Treatment Centre, Clinic 5, Sherwood Forest Hospitals Foundation Trust, Nottinghamshire, England (iidris@aol.com))

JOURNAL : Archives of Internal Medicine

REFERENCE: 172(13):1005-11

DOI : 10.1001/archinternmed.2012.1938

Association Between Thiazolidinedione Treatment and Risk of Macular Edema Among Patients With Type 2 Diabetes

More publications

Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis

Using repeated measurements to predict cardiovascular risk in patients with type 2 diabetes Mellitus

Inequalities in the management of diabetic kidney disease in UK primary care: A cross-sectional analysis of a large primary care database